Response to hyperfractionated accelerated radiotherapy in chemotherapy-refractory non-Hodgkin lymphoma

Daniel W. Kim,Grace M. Lee,Hwan Lee,Amandeep R. Mahal,Miranda B. Lam,Andrea K. Ng

Response to hyperfractionated accelerated radiotherapy in chemotherapy-refractory non-Hodgkin lymphoma

2020

Daniel W. Kim
Grace M. Lee
Hwan Lee
Amandeep R. Mahal
Miranda B. Lam
Andrea K. Ng

AbstractPatients with chemotherapy-refractory non-Hodgkin lymphoma (NHL) have a poor prognosis with a median overall survival (OS) of only 10 months. To investigate the role of radiotherapy (RT) in...

Keywords:

Oncology
Hematopoietic stem cell transplantation
Refractory Non-Hodgkin Lymphoma
Immunology
Radiation therapy
Internal medicine
Lymphoma
Medicine
Diabetes mellitus
Chemotherapy
hyperfractionated accelerated radiotherapy
poor prognosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations